Eton Pharmaceuticals Inc expected to post a loss of 4 cents a share - Earnings Preview

Eton Pharmaceuticals

12/03/2024 20:55

* Eton Pharmaceuticals Inc  ETON.OQ   ETON.O  is expected
to show
a fall in quarterly revenue when it reports  results on March 14
for the period ending December 31 2023
    * The Deer Park Illinois-based  company is expected to
report a
9.4% decrease in revenue to $7.7 million from $8.5 million a
year ago, according to the estimate from one analyst, based on
LSEG data.
    * ​LSEG's mean analyst estimate for Eton Pharmaceuticals Inc
is
for a loss of 4 cents per share. 
    * The one available analyst rating on the shares is "buy".  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Eton
Pharmaceuticals Inc is $10.00​, above​ its last closing price
of $4.56. ​​​

This summary was machine generated March 12 at 20:55 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)